STAT

JUNE 12, 2023

Brain responses to nutrients in the gut are impaired in people with obesity, and that doesn’t change even after they lose weight through changes in diet, a new study finds, adding to mounting research showing the complexity and persistence of the biological effects of obesity. Using brain imaging, researchers saw that when people without obesity received nutrients, they experienced reduced activity in areas of the brain involved in food intake, suggesting the brain is signaling to them th

312

312

PharmaVoice

JUNE 12, 2023

Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction.

246

246

STAT

JUNE 12, 2023

In February 2022, Diego Miralles, then-CEO of a buzzy new biotech called Laronde, gathered his employees in the company’s shiny new Somerville, Mass., headquarters to relay some unsettling news. An internal investigation had uncovered a “bad assay” and poor note-taking in some of the core research being conducted at the company, Miralles told Laronde’s roughly 130 staffers.

246

246

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). The webinars will focus on unintended consequences for patient access that may result from the implementation of IRA provisions.

Biosimilars 130

Biosimilars Drug Pricing Compounding Drug Development 130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 12, 2023

Companies, unions, and workers are at a breaking point over how much they pay for health coverage. And some are so exasperated that they’re fighting their own health insurance carriers in court. A string of new lawsuits and judge orders highlights employers’ frustration with health insurers, who they believe are allowing hospitals, doctors, and other entities to charge flagrantly high prices with little to no pushback — knowing that employers and workers will ultimately pick

Hospitals 244

Hospitals 244

PharmaVoice

JUNE 12, 2023

While online cookies revolutionized online advertising and are a big part of a $600 billion dollar industry, targeting consumer/patient behavior is about to get much more difficult

130

130

PharmaVoice

JUNE 12, 2023

Focused on making a “transformational” impact, the company is developing targeted treatments driven by specific cancer mutations.

130

130

STAT

JUNE 12, 2023

Telehealth company Ro has paused advertising of the obesity drug Wegovy as the drug suffers shortages, a reversal in aggressive promotional efforts by the provider that involved splashy ads in subway stations. Novo Nordisk, the maker of Wegovy, said last month it would limit its starting doses for new patients and pause advertising of the drug to avoid stimulating further demand.

221

221

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). The webinars will focus on unintended consequences for patient access that may result from the implementation of IRA provisions.

Biosimilars 100

Biosimilars Drug Pricing Compounding Drug Development 100

BioPharma Dive

JUNE 12, 2023

Decentralized clinical trials (DCTs) bring many benefits to the clinical research process, and more importantly, the patients. However, it is important to remember the risks if there is no data security process in place.

106

106

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Safe Biologics

JUNE 12, 2023

Op-ed: IRA Drug Price Controls Will Hurt Cancer Drug Development On May 18th, an op-ed by ASBM Steering Committee Member Andrew Spiegel ran in the Reading Eagle. Mr. Spiegel is a founding member of ASBM and Executive Director of the Global Colon Cancer Association. In the op-ed, Spiegel highlights the importance of small-molecule drugs in cancer therapy, and notes how the IRA disincentivizes their development: The rate of colorectal cancer in Americans under 55 has nearly doubled since the 1

Drug Pricing 100

Drug Pricing Drug Development Compounding 100

Pharma Times

JUNE 12, 2023

The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes

121

121

Safe Biologics

JUNE 12, 2023

Op-ed: IRA Drug Price Controls Will Hurt Cancer Drug Development On May 18th, an op-ed by ASBM Steering Committee Member Andrew Spiegel ran in the Reading Eagle. Mr. Spiegel is a founding member of ASBM and Executive Director of the Global Colon Cancer Association. In the op-ed, Spiegel highlights the importance of small-molecule drugs in cancer therapy, and notes how the IRA disincentivizes their development: The rate of colorectal cancer in Americans under 55 has nearly doubled since the 1

Drug Pricing 100

Drug Pricing Drug Development Compounding 100

BioPharma Dive

JUNE 12, 2023

DeSouza is departing unrepentant about his decision to close the Grail deal, telling colleagues his belief in the merger “remains unshakeable.

109

109

The Pharmacist

JUNE 12, 2023

Pharmacy bodies have spoken out against an increasing number of medicine recalls and notifications that pharmacy teams are having to deal with. This included the Association of Independent Multiple Pharmacies (AIMp), which has called for an inquiry into the cause of the issue. The number of medicine recalls and patient safety alerts have increased in […] The post Call for inquiry as medicine recalls and alerts increase appeared first on The Pharmacist.

Community Pharmacies 95

Community Pharmacies 95

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure. The company is a specialised pharmaceutical wholesaler and holds a licence, issued by the country’s ministry of health, to import non-registered pharmaceutical products, orphan drugs and other life-saving medicines.

97

97

European Pharmaceutical Review

JUNE 12, 2023

Novo Nordisk intends to invest 15.9 billion Danish kroner (€2.1 billion) to expand an existing active pharmaceutical ingredient (API) production facility in Hillerød, Denmark. The investment, which begins in 2023, will create additional production capacity and increase Novo Nordisk’s ability to meet future market demands. “This important investment will ensure the continuous development of our late-phase pipeline into deliveries of important medicines for treatments to patients worldwide,” state

87

87

World Pharma News

JUNE 12, 2023

AstraZeneca has entered into an exciting collaboration, exclusive option and license agreement with Quell Therapeutics to develop multiple engineered T-regulator (Treg) cell therapies that have the potential to be curative in Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD) indications. Under the terms of the agreement, Quell's proprietary toolbox of Treg cell engineering modules, including its innovative Foxp3 Phenotype Lock will be leveraged to develop autologous multi-modular Treg c

Diabetes 85

Diabetes 85

Pharma Times

JUNE 12, 2023

Objective response rate and complete response rates were encouraging for both treatments - News - PharmaTimes

99

99

Express Pharma

JUNE 12, 2023

The European Commission (EC) recently approved GSK’s novel vaccine, Arexvy, for the prevention of lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older, making it the first RSV vaccine available across the EU. Arexvy was also approved by the FDA in May, becoming the first RSV vaccine authorized for use in the US.

Vaccines 78

Vaccines 78

BioPharma Dive

JUNE 12, 2023

The Swiss pharma is betting that two experimental drugs the biotech has developed for IgA nephropathy will succeed in late-stage testing, one of which will deliver results later this year.

68

68

pharmaphorum

JUNE 12, 2023

Driving improved and equitable outcomes for IBD patients across all stages of life Mike.

95

95

BioPharma Dive

JUNE 12, 2023

The company said the spending will help it manufacture future treatments for chronic diseases, adding to a string of recent plant investments.

77

77

pharmaphorum

JUNE 12, 2023

Veeva R&D and Quality Summit: Delivering next-generation innovation for patients Mike.

94

94

Express Pharma

JUNE 12, 2023

JB Pharma’s formulations manufacturing facility – T20 located at Panoli, Gujarat was inspected by the USFDA. The inspection was conducted from June 5-9, 2023. The company informed that at the end of the inspection, the facility received “No Observations” and thus no Form 483 was issued. A statement from JB Pharma said, “The company remains committed to producing quality products, embedding a quality culture across the organisation and continuously investing in systems, processes and

63

63

pharmaphorum

JUNE 12, 2023

Healthware Group, Digital Therapeutics Alliance launch DTx policy report and website Nicole.

90

90

Pharmaceutical Technology

JUNE 12, 2023

Clinical-stage biotechnology firm Eccogene has raised $25.23m (CNY180m) in a Series B financing round to support the development of its clinical-stage metabolic pipeline. Co-led by Zhangjiang Healthcare Venture Capital and New Alliance Capital, the financing round has seen participation from existing investors Qingsong Capital, Delos Capital and Oriza Seed Capital.

Diabetes 59

Diabetes 59

pharmaphorum

JUNE 12, 2023

The rise of tech bio: Powering life science innovation Mike.

98

98

Pharmaceutical Technology

JUNE 12, 2023

Novartis will buy US-based clinical-stage biopharmaceutical company Chinook Therapeutics in a $3.5bn deal. Chinook common stockholders will receive $3.2bn and $0.3bn in cash through contingent value rights upon achieving certain regulatory milestones. The deal is a merger of a newly formed subsidiary of the company with Chinook, which has two late-stage medicines currently under development to treat IgA nephropathy (IgAN), a rare, progressive chronic kidney disease.

59

59

pharmaphorum

JUNE 12, 2023

Beacon debut sheds light on Syncona’s gene therapy plans Phil.

92

92

Viseven

JUNE 12, 2023

The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. Though we’re witnessing fundamental changes all over the world, each region has its peculiarities dictated by multiple local factors. In this article, we’ll focus on a pharmaceutical market in the APAC region, go through the differences between pharma in APAC and pharma in other parts of the world, and see the current state of the APAC pharma market.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

Welltopia Pharmacy

JUNE 12, 2023

Discover the benefits and proper usage of hydrocortisone cream for acne treatment. Learn how it reduces inflammation, calms breakouts, and improves the appearance of acne-prone skin.

Dosage 52

Dosage Compounding 52

BioPharma Dive

JUNE 12, 2023

CVS Health was one of the first retailers to launch a clinical trials business. But a number of other competitors followed, arguing they could provide easier access and more diverse studies.

52

52

PharmaState Academy

JUNE 12, 2023

Thank you for the payment. Please check your email id (Inbox/spam/other folders) for the payment reciept. You will be added to a WhatsApp group within 1 day. Happy Learning! - PharmaState Academy #FromYouToYou+ The post Thank you for the payment appeared first on PharmaState Academy.

52

52

Pharmaceutical Technology

JUNE 12, 2023

The global pharmaceutical industry experienced a 120% rise in company filings mentions of internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for by Moderna, according to GlobalData’s analysis of over 61 pharmaceutical company filings. The growing application of Internet of Things will prove to have a transformative impact across the Healthcare sector.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52